Search

everythinglearnresearchcommunity

for

Search:↓

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Inhaled steroids in children may cause excessive hair growth and not always go away after stopping the medication.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

The document concludes that hair loss in cats is caused by various factors, including allergies, mites, infections, and hormonal issues, with treatments varying accordingly.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.

The effects of estrogen on human scalp hair growth are unclear and need more research.

PCOS patients, especially obese ones, often lack vitamin D and may need supplements and lifestyle changes.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

Pregnancy can cause skin pigmentation, stretch marks, and changes in hair, nails, and sweat glands, with most resolving after birth.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

Minoxidil promotes hair regrowth, but more research needed for effectiveness and response factors.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Adult esophageal cells can start to become like skin cells, with a key pathway influencing this change.

Blocking 11β-HSD1 can lessen the harmful effects of glucocorticoids on hair growth cells.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

The enzyme myo-inositol oxygenase is not linked to the cause of polycystic ovarian syndrome.

Phytotherapeutic compounds and supplements can help manage Polycystic Ovarian Syndrome (PCOS).

Skin lesions in Carney complex are likely caused by a specific group of skin cells that promote pigment production due to a genetic mutation.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Hyperpigmentation is common in pregnancy and may not fully fade after birth; melasma, also frequent, can persist but has limited treatment options during pregnancy.